Infection
Cephalosporins
β-Lactam antibiotics related to penicillins, more stable to many β-lactamases; later generations reach more gram-negative bacteria. Used for pyelonephritis, intra-abdominal and biliary infections and many others.
Mécanisme d’action
- Like penicillins, they bind penicillin-binding proteins and stop cell wall cross-linking.
- Each generation broadens activity against gram-negative bacteria: ceftriaxone and cefotaxime (third generation) reach Enterobacterales; ceftazidime and cefepime reach Pseudomonas.
- They do not cover enterococci or anaerobes well, so metronidazole is added for abdominal infections.
Cibles moléculaires
- Penicillin-binding proteins: Irreversible inhibitor
Médicaments : Cephalosporins
First generation
- Cefalexin (First generation, by mouth.)
Second generation
- Cefuroxime (Second generation.)
Third generation
- Ceftriaxone (Third generation; once daily.)
Fourth generation
- Cefepime (Fourth generation.)
Indications thérapeutiques
- Acute pyelonephritis and complicated urinary infection
- Acute appendicitis and cholecystitis, with metronidazole
- Pneumonia and meningitis (ceftriaxone)
- Infective endocarditis due to some streptococci (ceftriaxone)
Maladies traitées
Effets indésirables
- Hypersensitivity
- Clostridioides difficile diarrhoea
- Biliary sludge (ceftriaxone)
Contre-indications selon le terrain
- Anaphylaxis to a penicillin (Contre-indiqué): Cross-reactivity is low but real; they are avoided after a severe immediate reaction.
- Ceftriaxone with intravenous calcium in newborns (Contre-indiqué): Calcium–ceftriaxone precipitates can form in the lungs and kidneys.
Sujets liés
Rédigé d’après
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 29, Cell Wall Inhibitors, Cephalosporins
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 43, Beta-Lactam & Other Cell Wall- & Membrane-Active Antibiotics, Cephalosporins & cephamycins
Ressource pédagogique. Ne constitue pas un avis, un diagnostic ou un traitement médical.